0 CHECKOUT

Calming and Sleeping in Finland

  • ID: 1830056
  • March 2015
  • Region: Finland
  • 41 pages
  • Euromonitor International

Calming and sleeping products increased by a dynamic 16% in current value terms in 2014. The vibrant performance was the result of a long series of new launches during 2013 and 2014. The development was a result of the new regulatory status of melatonin in Finland following a decision by The Finnish Medicine Agency (FIMEA) in November 2013, stating that products containing 0.5-1 mg of melatonin can be sold as dietary supplements and marketed with the European Commission approved health claims.

The Calming and Sleeping in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Calming and Sleeping market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

CALMING AND SLEEPING IN FINLAND

March 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2009-2014
Table 2 Sales of Calming and Sleeping: % Value Growth 2009-2014
Table 3 NBO Company Shares of Calming and Sleeping: % Value 2010-2014
Table 4 LBN Brand Shares of Calming and Sleeping: % Value 2011-2014
Table 5 Forecast Sales of Calming and Sleeping: Value 2014-2019
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2014-2019
Hankintatukku Arno Latvus Oy in Consumer Health (finland)
Strategic Direction
Key Facts
Summary 1 Hankintatukku Arno Latvus Oy: Key Facts
Summary 2 Hankintatukku Arno Latvus Oy: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Hankintatukku Arno Latvus Oy: Competitive Position 2014
Midsona Finland Oy in Consumer Health (finland)
Strategic Direction
Key Facts
Summary 4 Midsona Finland Oy: Key Facts
Summary 5 Midsona Finland Oy: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Midsona Finland Oy: Competitive Position 2014
Orion Oyj in Consumer Health (finland)
Strategic Direction
Key Facts
Summary 7 Orion Oyj: Key Facts
Summary 8 Orion Oyj: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Orion Oyj: Competitive Position 2014
Verman Oy Ab in Consumer Health (finland)
Strategic Direction
Key Facts
Summary 10 Verman Oy Ab: Key Facts
Summary 11 Verman Oy Ab: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Verman Oy Ab: Competitive Position 2014
Yliopiston Apteekki Oy in Consumer Health (finland)
Strategic Direction
Key Facts
Summary 13 Yliopiston Apteekki Oy: Key Facts
Summary 14 Yliopiston Apteekki Oy: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 15 Yliopiston Apteekki Oy: Competitive Position 2014
Executive Summary
Consumer Health Sees Healthy Growth Despite Weak Economy in the Country
New Products and Health Trend Are the Main Drivers of Growth
International Players Dominate the Fragmented Consumer Health
Chemists/pharmacies Losing Out To Internet and Grocery Channels
Healthy Growth Forecast, But Slowly Settling Down
Key Trends and Developments
Consumer Health in Finland Is Fairly Strictly Controlled
Growing Consumer Confidence and Technical Advances Boost Internet Retailing
Segmentation Increasingly Important in Maturing Consumer Health
Rural Vs Urban Key Trends and Developments
Trends
Competitive Landscape
Prospects
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 8 Life Expectancy at Birth 2009-2014
Market Data
Table 9 Sales of Consumer Health by Category: Value 2009-2014
Table 10 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 11 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 12 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2009-2014
Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 16 OTC: Switches 2012-2014
Definitions
Sources
Summary 17 Research Sources

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Corporation
  • Merck & Co., Inc.